Concepedia

Thomas Sciascia

TS

Statistics

Publications

10

Citations

489

H-Index

10

Active since

1986

Affiliations

Trevi Therapeutics (United States)(Current)

University Hospital Münster

Wroclaw Medical University

University of Miami

Wilmington University

Thomas Sciascia is an author at Trevi Therapeutics (United States) specializing in cardiology, medicine, and cardiovascular disease.

Top concepts

Publications per year

1986–2023

10

Publications

10

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus

Vandana Mathur, Kumar Jayant, Paul W. Crawford et al. · American Journal of Nephrology · 2017 · 94 citations

A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial

David R. Lynch, Steven M. Willi, Robert B. Wilson et al. · Movement Disorders · 2012 · 89 citations

Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus

Amale Hawi, Harry Alcorn, Jolene Kay Berg et al. · BMC Nephrology · 2015 · 66 citations · Full text

Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis

Toby M. Maher, Cristina Avram, Enoch Bortey et al. · NEJM Evidence · 2023 · 57 citations · Full text

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits

Brian Kim, Saadet Inan, Sonja Ständer et al. · Experimental Dermatology · 2022 · 52 citations · Full text

1–5 of 10